Adding rituximab to other biologics may be safe in rheumatoid arthritisIn an open-label study to investigate the safety of combining biologic agents in the treatment of rheumatoid arthritis, researchers found little serious risk when rituximab (Rituxan) was added to other drugs. Clinical Notes: Orlistat safety questionedRisk of acute kidney injury increased within one year of starting the antiobesity drug orlistat, study finds. Vimovo: first NSAID–PPI combo now available in Canada AstraZeneca introducing first fixed-dose combination product containing a nonsteroidal anti-inflammatory drug and proton pump inhibitor. NHP Forum: Preventing and treating osteoporosis Exploring natural options for the treatment of osteoporosis. Vitamin D fails to relieve knee osteoarthritis pain Impotency drug cures Raynaud’s fingertip ulcers Vaccinations not linked to rheumatoid arthritis Colchicine safe for patients with comorbidities Arthritis biologics may cut Alzheimer’s risk Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says First Previous 16 17 18 19 20 Next Last